Nutrition and HIV Progression

营养与艾滋病毒进展

基本信息

  • 批准号:
    8067977
  • 负责人:
  • 金额:
    $ 30.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-05-20 至 2014-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): There are more than 40 million individuals infected with HIV living throughout the world, the majority of these live within the resource-limited world. It has been clear throughout the HIV epidemic that the nutritional status of the host plays an important, independent role in HIV-associated outcomes particularly progression of HIV disease and mortality. Although it would appear to be intuitive that maintenance of or improvement in nutritional status would lead to improved outcomes in HIV infected individuals, few data are available to demonstrate the potential benefits of maintaining nutrition status at normal. There are data that suggest that the use of micronutrients could reduce CD4 count decline and delay death, however micronutrients alone will not support or maintain nutritional status. The overall hypothesis of this application is that the consumption of a nutrient dense protein supplement (NDPS) early in HIV infection will slow disease progression, and that the time from infection with HIV to the initiation of HAART will be prolonged. If this hypothesis is proven to be correct, this type of intervention will result in benefit to the individual, as the need for the use of HAART would be delayed. It would also benefit the health systems, as cost savings would result from a delay in the initiation of HAART. Specifically we propose to enroll 740 HIV infected women in Kenya, with CD4 counts between 350 cells/<L and 500 cells/<Land no symptoms, opportunistic infections or AIDS defining illnesses or malnutrition (BMI <18.5 kg/m2) that would require the initiation of HAART. These individuals with early disease will be randomized to a group that will be provided with the nutrient dense protein supplement (NDPS) or standard of care (SOC) and followed until the initiation of HAART is necessary or a total of 2 years. Outcomes in this study will include the need for the initiation of HAART, the rate of decline of CD4 cell count, overall nutritional status as measured by BMI and lean body mass, and quality of life. We will determine the cost effectiveness of this intervention strategy. In order determine if the dietary intake and the nutritional status (BMI) of the HIV-infected women with early disease is within the community norm, we need to evaluate the dietary intake and nutritional status of similar but non HIV-infected women in the local community. We propose to collect data on 200 women who are documented to be HIV-negative from Voi Division at a single visit, the Division that will also provide the HIV -infected women for the intervention study.
描述(申请人提供):全世界有4000多万艾滋病毒感染者,其中大多数人生活在资源有限的世界里。在整个艾滋病毒流行过程中,很明显,宿主的营养状况对艾滋病毒相关后果,特别是艾滋病毒疾病的进展和死亡率起着重要的、独立的作用。尽管维持或改善营养状况会改善艾滋病毒感染者的结局似乎是直观的,但几乎没有数据可以证明将营养状况保持在正常水平的潜在好处。有数据表明,使用微量营养素可以减少CD4计数的下降并延缓死亡,但仅使用微量营养素不能支持或维持营养状态。这一应用的总体假设是,在艾滋病毒感染早期服用营养密集蛋白补充剂(NDP)将减缓疾病进展,并且从感染艾滋病毒到开始HAART的时间将延长。如果这一假设被证明是正确的,这种类型的干预将使个人受益,因为使用HAART的需要将被推迟。这也将使卫生系统受益,因为推迟启动HAART将节省成本。具体地说,我们建议在肯尼亚招募740名感染艾滋病毒的妇女,CD_4细胞数在350个/&lt;L到500个/&lt;之间,没有任何症状、机会性感染或艾滋病定义了需要启动HAART的疾病或营养不良(BMI&lt;18.5 kg/m2)。这些早期疾病患者将被随机分成一组,给予营养密集蛋白补充剂(NDPS)或标准护理(SOC),并进行跟踪,直到需要开始HAART或总共2年。这项研究的结果将包括启动HAART的必要性、CD4细胞计数的下降速度、以BMI和瘦体重衡量的总体营养状况以及生活质量。我们将确定这一干预策略的成本效益。为了确定患有早期疾病的艾滋病毒感染妇女的膳食摄入量和营养状况是否在社区正常范围内,我们需要评估当地社区类似但未感染艾滋病毒的妇女的膳食摄入量和营养状况。我们建议从VOI司收集记录为艾滋病毒阴性的200名妇女的数据,该司也将为干预研究提供艾滋病毒感染妇女。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christine A Wanke其他文献

Christine A Wanke的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christine A Wanke', 18)}}的其他基金

Training Program in Nutrition and Metabolism in HIV
艾滋病毒营养和代谢培训项目
  • 批准号:
    8516274
  • 财政年份:
    2013
  • 资助金额:
    $ 30.43万
  • 项目类别:
Training Program in Nutrition and Metabolism in HIV
艾滋病毒营养和代谢培训项目
  • 批准号:
    8806624
  • 财政年份:
    2013
  • 资助金额:
    $ 30.43万
  • 项目类别:
The Impact of Omega three Fatty Acids on Vascular Function and cIMT in HIV
欧米茄三脂肪酸对 HIV 患者血管功能和 cIMT 的影响
  • 批准号:
    8300894
  • 财政年份:
    2009
  • 资助金额:
    $ 30.43万
  • 项目类别:
The Impact of Omega three Fatty Acids on Vascular Function and cIMT in HIV
欧米茄三脂肪酸对 HIV 患者血管功能和 cIMT 的影响
  • 批准号:
    7939695
  • 财政年份:
    2009
  • 资助金额:
    $ 30.43万
  • 项目类别:
The Impact of Omega three Fatty Acids on Vascular Function and cIMT in HIV
欧米茄三脂肪酸对 HIV 患者血管功能和 cIMT 的影响
  • 批准号:
    8079697
  • 财政年份:
    2009
  • 资助金额:
    $ 30.43万
  • 项目类别:
The Impact of Omega three Fatty Acids on Vascular Function and cIMT in HIV
欧米茄三脂肪酸对 HIV 患者血管功能和 cIMT 的影响
  • 批准号:
    8493819
  • 财政年份:
    2009
  • 资助金额:
    $ 30.43万
  • 项目类别:
Nutrition and HIV Progression
营养与艾滋病毒进展
  • 批准号:
    8463821
  • 财政年份:
    2009
  • 资助金额:
    $ 30.43万
  • 项目类别:
Nutrition and HIV Progression
营养与艾滋病毒进展
  • 批准号:
    7982922
  • 财政年份:
    2009
  • 资助金额:
    $ 30.43万
  • 项目类别:
Nutrition and HIV Progression
营养与艾滋病毒进展
  • 批准号:
    7612596
  • 财政年份:
    2009
  • 资助金额:
    $ 30.43万
  • 项目类别:
Nutrition and HIV Progression
营养与艾滋病毒进展
  • 批准号:
    8288249
  • 财政年份:
    2009
  • 资助金额:
    $ 30.43万
  • 项目类别:

相似海外基金

I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 30.43万
  • 项目类别:
    Standard Grant
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 30.43万
  • 项目类别:
    Operating Grants
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 30.43万
  • 项目类别:
    Grant for R&D
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 30.43万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 30.43万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 30.43万
  • 项目类别:
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 30.43万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 30.43万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 30.43万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 30.43万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了